Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03749863 · ClinicalTrials.gov registry record · NA
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
A NA study of Dysphonia and Presbylarynx, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT03749863: Completed NA study of Dysphonia and Presbylarynx, sponsored by University of Southern California.
NCT03749863 is a NA study of Dysphonia and Presbylarynx that has completed, run by University of Southern California. The registered enrollment target is 14 participants, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03749863, a NA study of Dysphonia and Presbylarynx, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will investigate the safety and efficacy of four serial monthly vocal fold injections of platelet-rich plasma to treat dysphonia secondary to vocal fold atrophy, scar, and/or sulcus vocalis with glottal insufficiency
Primary Outcome
Adverse event severity grading scale from 1 to 4, with grade 1 as mild, grade 2 as moderate, grade 3 as severe, and grade 4 potentially life-threatening
Conditions Studied
Interventions
- PROCEDURE Serial PRP injections
Study Locations (1)
California
- University of Southern California - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2020-02-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT03749863 record still lists
NCT03749863 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 7 other Dysphonia trials with a reported enrollment target (77% lower).
The record links to 7 conditions, with Dysphonia appearing as the primary indexed condition, and to 1 intervention - of which Serial PRP injections is the first listed.
NCT03749863 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03749863 about?
NCT03749863 is a clinical study titled "Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis". This study will investigate the safety and efficacy of four serial monthly vocal fold injections of platelet-rich plasma to treat dysphonia secondary to vocal fold atrophy, scar, and/or sulcus vocalis with glottal insufficiency
What is the current status of trial NCT03749863?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2020-02-18. Estimated completion is 2022-09-30.
What conditions does trial NCT03749863 study?
This clinical trial studies the following conditions: Dysphonia, Presbylarynx, Atrophy; Larynx, Vocal Cord Atrophy, Presbylarynges.
What interventions are being tested in trial NCT03749863?
The interventions under investigation include: Serial PRP injections (PROCEDURE).
Who is sponsoring clinical trial NCT03749863?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03749863 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
RECRUITING · NA
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Silk Protein Microparticle-based Filler for Injection Augmentation
COMPLETED · NA
-
Intensive Versus Traditional Voice Therapy
COMPLETED · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy